Allurion Announces Launch of Offering of Common Stock and Warrants
Allurion Technologies, Inc. (ALUR)
Company Research
Source: Business Wire
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the “Shares”), and warrants to purchase Shares (the “Warrants” and, together with the Shares, the “Securities”).Jefferies and TD Cowen are acting as joint book-running managers and representatives of the underwriters for the offering. Roth Capital Partners is acting as co-manager for the offering. The Company expects to grant the underwriters a 30-day option to purchase additional Securities in an amount equal to 15% of the Securities offered in the offering.The Company intends to use the net proceeds from the underwritten public offering and the concurrent private placement discussed below to continue to fund clinical trials, commercial sales and research and development, and for working capital and ge
Show less
Read more
Impact Snapshot
Event Time:
ALUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALUR alerts
High impacting Allurion Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
ALUR
News
- Allurion Technologies: Study Results Cause Rally, But I'm Awaiting 2024 FDA Catalyst [Seeking Alpha]Seeking Alpha
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss [Yahoo! Finance]Yahoo! Finance
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight LossBusiness Wire
- Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy [Yahoo! Finance]Yahoo! Finance
- Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]Yahoo! Finance
ALUR
Earnings
- 3/21/24 - Beat
ALUR
Sec Filings
- 6/28/24 - Form 424B4
- 6/27/24 - Form EFFECT
- 6/27/24 - Form EFFECT
- ALUR's page on the SEC website